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Objective: These studies investigated cytokine and chemokine receptor proﬁles in nucleus pulposus (NP)
cells, and the effects of receptor stimulation on mRNA levels of extracellular matrix (ECM) components,
degrading enzymes and cytokine and chemokine expression.
Method: Immunohistochemistry (IHC) was performed to localise expression of CD4, CCR1, CXCR1 and
CXCR2 in human NP tissue samples. Effects of cytokine and chemokine stimulation was performed to
investigate effects related to ECM remodelling and modulation of cytokine and chemokine mRNA
expression.
Results: IHC identiﬁed CD4, CCR1, CXCR1 and CXCR2 expression by NP cells. Differential expression
proﬁles were observed for CD4 and CXCR2 in tissue samples from degenerate and inﬁltrated IVDs. In vitro
stimulations of primary human NP cultures with IL-16, CCL2, CCL3, CCL7 or CXCL8 did not identify any
modulatory effects on parameters associated with ECM remodelling or expression of other cytokines and
chemokines. Conversely, IL-1 was seen to modulate ECM remodelling and expression of all other cyto-
kines and chemokines investigated.
Conclusion: This study demonstrates for the ﬁrst time that NP cells express a number of cytokine and
chemokine receptors and thus could respond in an autocrine or paracrine manner to cytokines and
chemokines produced by NP cells, particularly during tissue degeneration. However, this study failed to
demonstrate regulatory effects on ECM genes and degradative enzymes or other cytokines and che-
mokines for any target investigated, with the exception of IL-1. This suggests that IL-1 is a master
regulator within the IVD and may exert regulatory potential over a plethora of other cytokines and
chemokines.
© 2015 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.ECM, extracellular matrix; MMP, matrix metalloproteinase; ADAMTS, a disintegrin and metalloproteinase with
ur necrosis factor; NP, nucleus pulposus; CCL, CeC chemokine ligand; CXCL, C-X-C chemokine ligand; CD, cluster of
CR, C-X-C chemokine receptor; PM, post-mortem; AF, annulus ﬁbrosus; CEP, cartilaginous end plate; IHC,
g, immunoglobulin; DMEM, Dulbecco's modiﬁed eagle medium; RNA, ribonucleic acid; cDNA, complementary
; GAPDH, glyceraldehyde 3-phospate dehydrogenase; 18S, 18S ribosomal RNA; IFN, interferon; CSF, colony stimulating
lar endothelial growth factor; NF, nuclear factor; PDAR, pre-designed assay reagent.
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Table I
Tissue Donor and Sample Classiﬁcation Details. S, Surgical; PM, Post-mortem. Sur-
gically obtained prolapsed tissue samples were considered to be from ‘intact’ IVDs
when no signs of AF or CEP rupture were evident (protrusion type of prolapse).*
denotes tissue sample used for NP cell isolation. Grades are histologically deter-
mined grade of degeneration, Inﬁltrated means inﬁltrating immune cells were
observed
Ref. Source Age (y) Level Intact Cell isolation IHC Grade Inﬁltrated
1 S 42 L4/L5 No Y 3.50 Y
2 S 40 L5/S1 Yes * Y 4.50 Y
3 S 25 L4/L5 Yes Y 5.70 N
4 S 48 L4/L5 Yes * Y 4.70 Y
5 S e e e * Y 4.20 Y
6 S 62 L4/L5 Yes * Y 7.50 N
7 S 32 L5/S1 Yes * Y 2.90 N
8 S 53 L4/L5 No Y 3.50 Y
9 S 40 L5/S1 Yes Y 6.20 N
10 S 66 L5/S1 e Y 4.50 Y
11 S 34 L4/L5 Yes Y 9.20 N
12 S 29 L4/L5 Yes * N 7.80 Y
13 PM 45 L4/L5 Yes Y 2.00 N
14 PM 45 L4/L5 Yes Y 3.50 N
15 PM 45 L4/L5 Yes Y 5.00 N
16 S 48 L4/L5 No Y 8.40 N
17 S 26 L5/S1 No Y 3.90 N
18 S 33 L5/S1 Yes Y 4.50/7.40 Y
19 PM e L1/L2 Yes Y 5.50 N
20 PM e L4/L5 Yes Y 8.50 N
21 PM e L5/S1 Yes Y 8.00 N
22 PM e L3/L4 Yes Y 8.50 N
23 PM e L2/L3 Yes Y 9.00 N
24 S 36 L5/S1 Yes Y 5.90 N
25 S e e e Y 5.00 Y
26 S 44 L5/S1 Yes Y 4.40 Y
27 S 52 L4/L5 Yes Y 5.40 N
28 S e L4/L5 No Y 4.00 Y
29 S 38 L5/S1 No Y 4.50 Y
30 S 28 L4/L5 Yes * Y 7.40 N
31 S 43 L5/S1 No * N 5.5 N
32 S 40 L3/L4 Yes * N 7.4 N
33 S 45 L4/L5 No * N 2.6 Y
34 S 47 L2/L3 No * N 5.40 Y
35 S 39 L5/S1 Yes * N 3.9 Y
36 S 19 L5/S1 No * Y 5.20 N
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In the mature intervertebral disc (IVD), tissue homeostasis is
maintained by an isolated native cell population1e3. A continuous
process of tissue remodelling occurs whereby collagen and pro-
teoglycan synthesis is balanced by enzymatic extracellular matrix
(ECM) degradation4,5. The native IVD cell population produces ECM
degrading enzymes that facilitate degradation, and two families
have been identiﬁed; the matrix metalloproteinases (MMPs)6e8
and the a disintegrin and metalloproteinase with thrombo-
spondin motifs (ADAMTSs)9e11.
IVD cells mediate ECM remodelling as an adaptive response
to changes in the tissue microenvironment. Biochemical factors
such as oxygen and the substrates and products of anaerobic
metabolism12e15, and mechanical stimuli16e18 are seen to modu-
late the process, to maintain the functional integrity of tissue
structures.
IVD degeneration is characterised by dysregulated ECM
remodelling. Rates of ECM degradation are increased whilst ECM
synthesis is decreased4,5, resulting in the dehydration and func-
tional failure observed in degenerate IVDs19,20. A number of pro-
inﬂammatory cytokines have been implicated in the regulation of
ECM remodelling. Interleukin-1 (IL-1) and tumour necrosis factor-a
(TNF-a), both of which are increased in IVD degeneration21e25
induce ECM degrading enzymes and decrease synthesis of ECM
components in vitro25e27.
Articular chondrocytes exhibit biochemical and morphological
similarity to nucleus pulposus (NP) cells, indeed NP cells are often
referred to as ‘chondrocyte like’. Equilibrium between anabolic and
catabolic activity in articular chondrocytes can be pushed towards
catabolism by IL-1 and TNF-a stimulation28e30, in a similar way to
NP cells. Further, it has been observed that certain chemotactic
cytokines: ‘chemokines’, also promote catabolism in articular
chondrocytes. Particularly, CC and CXC chemokines are reported to
simulate the release of MMP-3 and N-acetyl-b-D-glucosaminidase
from articular chondrocytes31e33.
Chemokine expression within the IVD has been shown by a
number of previous studies34e39, and recently we reported that
the native NP cell population is a source of many cytokines and
chemokines within degenerate and prolapsed human IVDs40.
Further, we demonstrated that expression of CCL2, CCL7 and
CXCL8 increased concordant with histological degeneration40
and hence, chemokine expression may be linked to disease
severity in chronic low back pain (LBP) associated with degen-
eration and prolapse of the IVD. However, expression alone is not
sufﬁcient to implicate chemokines as biological mediators in the
pathogenesis of IVD degeneration or prolapse. Their roles within
the IVD have not been well investigated and it remains unclear
which cells may respond to chemokine signalling and also
whether chemokine signalling may elicit effects on ECM
remodelling. Our previous investigation putatively identiﬁed re-
ceptor expression by NP cells (at the mRNA level) for CD4 (IL-16
signalling receptor41e44), CCR1, CXCR1 and CXCR2 along with co-
expression of chemokine ligands, suggesting an autocrine or
paracrine signalling mechanism.
This study aimed to address the hypothesis that cytokines and
chemokines modulate NP cell behaviour in the human IVD. Spe-
ciﬁcally, we aimed to identify the expression of cytokine and che-
mokine receptors by NP cells to determine the capacity of NP cells
to respond to chemokine signalling in degenerate and prolapsed
human IVDs. Further, we aimed to determine the effects of stimu-
lation of identiﬁed receptors on primary human NP cell meta-
bolism, and to determine the inter-relationships between cytokine
and chemokine expression within the IVD.Materials & methods
Tissue samples processing and grading
Thirty six human lumbar IVD tissue samples were obtained for
use in this study, either at surgery or post-mortem examination
(PM) with informed consent of the patient or relatives (Table I).
Local ethics approval was given for this work by Shefﬁeld Research
Ethics Committee (09/H1308/70). Eight post-mortem IVDs were
recovered from two donors with no recorded history of IVD disease
or LBP. Twenty eight NP samples were recovered from patients
undergoing microdiscectomy for alleviation of root pain related to
IVD prolapse, samples were selected to provide representation of
non-degenerate, degenerate and inﬁltrated samples from discs
received with sufﬁcient NP tissue for study. Representative tissue
samples were ﬁxed in 10% v/v neutral buffered formalin (Leica,
Milton Keynes, UK) and processed to parafﬁn wax on a Shandon
Elliott Duplex Processor. Haematoxylin and eosin stained sections
were evaluated independently by two researchers (KLEP & CLLM)
to determine the extent of degenerative tissue changes. Sections
were scored numerically between 0 and 12 based on the presence
of cell clusters, ﬁssures, loss of demarcation and haematoxophilia; a
score of 0e3 indicates histologically non-degenerate IVDs and a
grade of 4 indicates evidence of degeneration, as describedn¼ 13 30
Table II
Real-time PCR Gene Expression Assays. PDAR, pre-designed assay reagent. Thresh-
olds were set within the exponential phase of PCR ampliﬁcation and maintained
across investigations. Ampliﬁcation efﬁciency was conﬁrmed for each assay used by
template titration
Target gene Assay Details (ID) Threshold Efﬁciency
18S PDAR (Hs99999901_s1) 0.75 99.6%
GAPDH PDAR (Hs99999905_m1) 0.75 99.4%
IL-1b PDAR (Hs01555413_m1) 0.75 94.7%
IL-16 PDAR (Hs00189606_m1) 0.25 95.3%
CCL2 PDAR (Hs00234140_m1) 0.50 96.4%
CCL3 PDAR (Hs00234142_m1) 0.50 97.7%
CCL7 PDAR (Hs00171147_m1) 0.50 96.2%
CXCL8 PDAR (Hs00174103_m1) 0.50 95.1%
Aggrecan Forward primer: TCGAGGACAGCGAGGCC 0.75 98.8%
Reverse primer: TCGAGGTAGCGTGTAGAGA
Probe: ATGGAACACGATGCCTTTCACCACGA
MMP-3 PDAR (Hs00233962_m1) 0.75 97.6%
MMP-13 PDAR (Hs00233992_m1) 0.40 96.5%
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chemical (IHC) analysis for CD11b expression and samples classi-
ﬁed as 'inﬁltrated' if CD11b immunopositivity was observed in any
tissue section from that patient as described previously37. On ac-
count of the heterogeneity often observed in prolapsed IVD tis-
sues45, serial sections were made from parafﬁn embedded tissues.
For each tissue section used for IHC, routine histology was per-
formed on an adjacent serial section, as such the grade assigned
was relevant to the tissue assessed by IHC.
Immunohistochemistry (IHC)
Four chemokine receptors were selected for IHC investigation
of protein production and localisation. Expression of each target
chemokine receptor was investigated in 30 IVD tissue samples
(Table I), divided between three study groups: non-degenerate;
degenerate and inﬁltrated. Brieﬂy, 4 mm parafﬁn sections were
dewaxed, rehydrated and endogenous peroxidase blocked using
hydrogen peroxide. After washing in tris buffered saline (TBS;
20 mM Tris, 150 mM sodium chloride, pH 7.5), sections were
subjected to heat induced antigen retrieval (10 min microwave
irradiation in 0.05 M tris buffer, pH 9.5). Following TBS washing,
non-speciﬁc binding sites were blocked at room temperature
(RT) for 90 min with 25%v/v rabbit serum (Abcam) in 1%w/v
bovine serum albumin (Sigma, Poole, UK) in TBS. Sections were
incubated overnight at 4C with mouse monoclonal primary
antibodies against human CD4(1:500), CCR1(1:1000),
CXCR1(1:2000) and CXCR2(1:500) (Abcam). Negative controls in
which mouse IgGs (Abcam) replaced the primary antibody at an
equal protein concentration were used. Following TBS washes,
sections were incubated in biotinylated rabbit anti-mouse anti-
serum (1:400; Abcam) for 30 min at RT. Disclosure of secondary
antibody binding was by HRP-streptavidin-biotin complex (Vec-
tor Laboratories, Peterborough, UK) technique with 0.08% v/v
hydrogen peroxide in 0.65 mg/mL 3,30-diaminobenzidine tetra-
hydrochloride (Sigma) in TBS. Sections were counterstained with
Mayer's Haematoxylin (Leica), dehydrated, cleared and mounted
in Pertex (Leica).
All slides were visualised using an Olympus BX60 microscope
and images captured using a digital camera and software program
QCapture Pro v8.0 (MediaCybernetics, Marlow, UK). Evaluation of
IHC was performed by counting 200 NP cells, with immunopositive
cells expressed as a percentage of total count.
NP cell isolation & culture
Surgical NP tissue samples were ﬁnely minced and digested
with 2 U/ml protease (Sigma) in DMEM (Gibco, Paisley, UK) for
30 min at 37C, followed by 2 mg/mL collagenase type I (Sigma) in
DMEM for 4 h at 37C. Cells were recovered by centrifugation and
washed in DMEM prior to seeding to 75 cm2 ﬂasks (Thermo Sci-
entiﬁc, Northumberland, UK) and maintenance in DMEM supple-
mented with 10% heat inactivated foetal bovine serum (Gibco),
200 U/mL penicillin/200 mg/mL streptomycin (Gibco), 500 ng/mL
amphotericin B (Sigma), 2 mM L-glutamine (Gibco) and 50 mg/mL
ascorbic acid (Sigma) (complete media). NP cultures were used for
experimental purposes up to and including passage two. Following
passage one, supplementation of culture media with antibiotics
was decreased by 50%. Cultures were maintained at all times at
37C and 5% CO2 in a humidiﬁed environment.
Alginate culture
Following expansion in monolayer, NP cells were re-suspended
in 1.2%w/v low viscosity alginic acid (Sigma) in 0.15 M sodium
chloride (Fisher Scientiﬁc, Loughborough, UK) at a density of2.0  106 cells/mL. Alginate beads were formed via extrusion
through a 19 gauge needle into 200 mM CaCl2 (Fisher Scientiﬁc),
washed twice in 0.15 M NaCl, once in complete media and main-
tained in complete media for 14 days prior to cytokine stimulation
with culture media changed twice weekly.
Chemokine stimulation of alginate cultures
Culture media was removed and replaced with either: complete
media supplemented with 0, 1, 10 or 100 pg/ml, or 1, 10 or 100 ng/
ml IL-1b, or complete media supplemented with 0, 1, 10 or 100 ng/
mL IL-16, CCL2, CCL3, CCL7 or CXCL8, and incubated for 48 h.
Following stimulation, conditioned media aliquots were collected
and stored frozen at 80C and RNA was extracted from alginate
cultures for use in quantitative real-time PCR (qRT-PCR). Stimula-
tions were performed in triplicate on alginate cultures derived from
each NP tissue sample, and on samples from at least three different
tissue donors (Table I).
qRT-PCR
NP cells were recovered from alginate culture by dissolving the
beads in alginate dissolving buffer (55 mM C6H6Na2O7 (Sigma);
30 mM EDTA (Fisher); 0.15 M NaCl; pH 6.0) for 10 min at 37C.
Following centrifugation cells were re-suspended in 0.06%w/v
type I collagenase and incubated for 10 min at 37C to digest
deposited ECM and cells recovered by centrifugation. RNA was
extracted using Qiagen RNeasy Mini kit (Qiagen, Crawley, UK) as
per manufacturers' protocol. cDNA was reverse transcribed using
Moloney Murine Leukaemia Virus reverse transcriptase (Bioline,
London, UK) and random hexamers (Applied Biosystems, War-
rington, UK). cDNA samples were interrogated by qRT-PCR for the
expression of cytokines, chemokines, ECM gene and ECM
degrading enzymes (Table II). Brieﬂy, a mastermix was prepared
for each target gene investigated and 0.5 mL gene expression assay
(Applied Biosystems; Table II), 5 mL Taqman® FAST® universal
mastermix (Applied Biosystems) and 2.5 mL sterile deionised
water and 2 mL sample cDNA per well loaded into 96-well FAST®
PCR plates. Plates were ran on a StepOnePlus real-time PCR ma-
chine (Applied Biosystems) for 50 cycles of denaturation at 95C
for 1 s followed by annealing and extension at 60C for 20 s mRNA
measurements were performed in duplicate per cDNA sample and
average Ct value derived. Relative gene expression levels were
calculated by 2DDCT method normalised to expression of two
internal reference genes (GAPDH and 18S; Table II) and un-
stimulated control samples. Stable expression of internal refer-
ence genes was conﬁrmed by geNorm algorithm.
K.L.E. Phillips et al. / Osteoarthritis and Cartilage 23 (2015) 1165e11771168Luminex immunoassays
Conditioned media recovered from IL-1b stimulated alginate
cultures were interrogated by Luminex multiplex bead immuno-
assay for the release of cytokines and chemokines. Commercially
available Cytokine 10-Plex and Chemokine 10-Plex bead immuno-
assays (Invitrogen, Paisley, UK) were multi-plexed and performed
as per manufacturers' protocol to simultaneously quantify 20
cytokine and chemokine analytes in each conditioned media
sample. Immunoassay measurements were performed in duplicate
per conditioned media sample and averaged. Analysis was per-
formed on Luminex xMap Technology platform with Luminex 100
Integrated System v2.3 software (Luminex Corporation, Austin,
USA). A standard curve for each analyte investigated was generated
to determine concentrations. Immunoassaymeasurements for each
analyte were then expressed as a concentration (pg/mL).
Statistical analysis
All data from this study was shown to be non-parametric and as
such statistical analysis for IHC data was performed against two
parameters: KruskaleWallis test with Conover-Ingman post-hoc
tests used to investigate signiﬁcant differences in expression level
between study groups; and non-parametric linear Regression
analysis was used to investigate correlations between immunopo-
sitivity and grade of degeneration. qRT-PCR data and luminex data
was analysed using a KruskaleWallis test with ConovereInman
post-hoc tests to investigate signiﬁcant differences in expression
levels between treatment groups. All Statistical analysis was per-
formed using statistical software: Stats-Direct.
Results
Chemokine receptor expression in human NP tissue
IHC conﬁrmed expression of the four chemokine receptors
investigated. Staining was localised to native NP cells [Fig. 1(A)], all
targets investigated except CCR1 expression was also observed in
immune cell inﬁltrates [Fig. 1(B)]. Expression of CXCR2 correlated
with grade of degeneration [P < 0.05:Fig. 2(A)] however, no cor-
relation was observed between expression of CD4, CCR1 or CXCR1
and grade of degeneration [P > 0.05:Fig. 2(A)]. However when
samples containing inﬁltrating cells were analysed compared to
non-degenerate and degenerate samples additional trends were
observed. Notably percentage of CD4 positive NP cells was
increased in pathological tissue samples (degenerate and inﬁl-
trated) compared to non-degenerate counterparts [P ¼ 0.0146 and
P ¼ 0.0098, respectively:Fig. 2(B)] further, it was observed that the
extent of CD4 expression by NP cells was signiﬁcantly higher in
inﬁltrated tissue samples than degenerate samples
[P ¼ 0.0228:Fig. 2(B)]. The percentage of CCR1, CXCR1 and CXCR2
immunopositive NP cells was equivalent between non-degenerate,
degenerate and inﬁltrated study groups [Fig. 2(B)].
Cytokine and chemokine modulation of ECM remodelling
To investigate the effects of stimulation of identiﬁed chemokine
receptors on the expression of genes associated with ECM remod-
elling, NP cells were treated with recombinant human IL-16 (ligand
to CD4), CCL2, CCL3, CCL7 (ligands to CCR1) or CXCL8 (ligand for
CXCR1 and CXCR2). The effects of recombinant human IL-1b stim-
ulation were also investigated across a wide range of concentra-
tions from 1 pg/ml to 100 ng/ml to determine the effects at in vivo
relevant concentrations. No signiﬁcant effects on mRNA expression
of aggrecan MMP-3 or MMP-13 were observed followingstimulationwith any chemokine investigated (Fig. 3 data shown for
0,100 ng/ml only). Conversely, IL-1b stimulation was seen to
modulate expression of all ECM associated genes investigated
(Fig. 3).
IL-1b stimulation of NP cells resulted in a concentration
dependent biphasic regulation of aggrecan mRNA, where low dose
IL-1b stimulation (100 pg/mL, signiﬁcant at 100 pg/mL,
P ¼ 0.0179) increased aggrecan expression, whilst high dose IL-1b
stimulation decreased expression (>1 ng/mL, signiﬁcant at 100 ng/
mL, P ¼ 0.0245:Fig. 3).
MMP-3 and MMP-13 mRNA expression was increased following
stimulation at all IL-1b concentrations investigated, signiﬁcantly for
MMP-3 at concentrations 10 pg/mL [P < 0.05:Fig. 3(B)] and
signiﬁcantly at all concentrations investigated for MMP-13
[P < 0.05:Fig. 3(B)].
Inter-regulation of cytokine and chemokine expression
Samples of cDNA derived from unstimulated and cytokine/
chemokine stimulated NP cultures were further interrogated to
determine the potential for cytokine and chemokine inter-
regulation in NP cells. No effects on mRNA expression of IL-16,
CCL2, CCL3, CCL7, CXCL8 or IL-1b were observed following stimu-
lationwith IL-16, CCL2, CCL3, CCL7 or CXCL8 (Fig. 4). Conversely, IL-
1b stimulationwas seen to modulate expression of all cytokine and
chemokine genes investigated (Fig. 4).
Basal expression of IL-16, CCL2, CCL7 and CXCL8, but not CCL3 or
IL-1b, was detected in NP cells. IL-1b increased expression of CCL2
(1 pg/ml (P < 0.05)), CCL7 (100 pg/mL (P < 0.05)) and CXCL8
(10 pg/mL (P < 0.05)) mRNA (Fig. 4). Further, IL-1b stimulation
was observed to induce expression of both CCL3 and IL-1bmRNA at
concentrations 10 pg/mL (Fig. 4), whilst these genes were not
expressed in any samples treated with any other cytokine or che-
mokine investigated. IL-1b stimulation also resulted in decreased
IL-16 mRNA expression, although this decrease was only signiﬁcant
at 1 ng/mL and 100 ng/mL concentrations (P < 0.05:Fig.4).
IL-1b modulated cytokine release
To conﬁrm that the observed regulatory potential of IL-1b on
cytokine and chemokine gene expression translates to modulation
of protein expression in NP cells Luminex multiplex bead immu-
noassay was utilized to enable wider characterisation of cytokine
and chemokine regulation by IL-1 stimulation.
Expression of IL-4, IL-6, IL-10, TNF-a, IFN-g and CSF2 was
conﬁrmed in conditioned media samples from unstimulated NP
cultures and IL-1b stimulation was seen to increase release of cy-
tokines from NP cells (Fig. 5). IL-6 and IFN-g release was signiﬁ-
cantly increased following IL-1b stimulationwith all concentrations
investigated (P < 0.05:Fig. 5). IL-4, IL-10, TNF-a and CSF2 release
was increased following IL-1b stimulation with all concentrations
investigated, signiﬁcantly so following stimulationwith 10 pg/mL
(P < 0.05:Fig. 5).
IL-1b modulated chemokine release
Expression of CCL2, CCL3, CCL4, CCL5, CCL7, CCL8, CXCL1,
CXCL8, CXCL9 and CXCL10 was conﬁrmed in conditioned media
samples from unstimulated NP cultures and IL-1b stimulation was
seen to increase release of all chemokines investigated, with the
exception of CCL8, from NP cells (Fig. 6). CCL2, CXCL1 and CXCL8
release was signiﬁcantly increased following IL-1b stimulation
with all concentrations investigated (P < 0.05:Fig. 6). CCL7 release
was signiﬁcantly increased following IL-1b stimulation at con-
centrations of 10 pg/mL (P < 0.05:Fig. 6). CCL3, CCL4, CCL5 and
CXCL9 release was signiﬁcantly increased following IL-1b stimu-
lation at concentrations 100 pg/mL (P < 0.05:Fig. 6). CXCL10
Fig. 1. CD4, CCR1, CXCR1 and CXCR2 Expression in Human NP Tissue. Representative photomicrographs showing 4 mm parafﬁn embedded sections of NP tissue stained for CD4,
CCR1, CXCR1 and CXCR2. A) Abundant CD4, CCR1, CXCR1 and CXCR2 expression was observed in NP cells scattered throughout tissue sections. B) CD4, CXCR1 and CXCR2 expression
was also seen by immune cell inﬁltrates (where present) in tissue sections, whilst expressionwas not observed in immune cell inﬁltrates for CCR1. Scale bars indicated A: 100 mm; B:
60 mm.
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was only signiﬁcant following 100 pg/mL stimulation
(P < 0.05:Fig. 6). CCL8 was the only chemokine investigated where
release from NP cells was not signiﬁcantly affected by IL-1b
stimulation (data not shown).
Discussion
The best studied functional roles of chemokines are in the
trafﬁcking of cells, particularly in relation to innate and adaptive
immune system responses and angiogenesis46. The implications of
their presence within the IVD, a normally immune privileged
avascular structure, have not been well studied. To date, no target
cells for chemokines within the intact IVD have been identiﬁed.This study is the ﬁrst, to the best of our knowledge, to investigate
the expression of chemokine receptors by native IVD cells.
In this study, we conﬁrmed by IHC the expression of chemokine
receptors: CD4; CCR1; CXCR1 and CXCR2 in the human IVD. Che-
mokine receptor expression was identiﬁed in both prolapsed sur-
gical NP tissues and non-degenerate PM NP tissues from donors
with no recorded history of IVD disease or LBP. Receptor expression
was localised to NP cells indicating the potential of NP cells to
respond to chemokine signalling. Receptor expression was also
identiﬁed on immune cell inﬁltrates. Leukocyte expression of
chemokine receptors is well documented with CD4 expression
most often related to T lymphocyte presence and CCR1, CXCR1 and
CXCR2 to macrophages and neutrophils47. Whilst CD4 expression
has been investigated previously in inﬂammatory inﬁltrates in
Fig. 2. Immunohistochemical (IHC) quantiﬁcation of CD4, CCR1, CXCR1 and CXCR2 Expression in Non-Degenerate (ND), Degenerate (D) and Inﬁltrated (I) IVDs. A) Linear Regression
of percentage immunopositivity for CD4, CCR1, CXCR1 and CXCR2 expression by NP cells against histologically determined grade of degeneration, tissues containing inﬁltrated cells
shownwith hollow circles whist those with no inﬁltrating cells shownwith solid circles. Non-parametric linear regression analysis of the full data set regardless of inﬁltrated status
shownwith line indicating NP cell CXCR2 immunopositivity increases concordant to histologically determined degenerative tissue changes n ¼ 30 (P < 0.05). B) IHC quantiﬁcation of
CD4, CCR1, CXCR1 and CXCR2 expression by NP cells in non-degenerate (ND) (n ¼ 3), degenerate (D) (n ¼ 16) and inﬁltrated (I) (n ¼ 11) IVDs. NP cell CD4 expression was increased
in degenerate and inﬁltrated samples, CCR1, CXCR1 and CXCR2 expression was not statistically different between study groups. Data shown are scatter plots indicating the
immunopositivity within each NP sample*, signiﬁcant difference in expression between study groups (P < 0.05).
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Fig. 3. IL-1b Stimulated Expression of Aggrecan, MMP-3 and MMP-13 mRNA in Primary Human NP Cultures. IL-1b stimulated a bi-phasic dose dependent aggrecan mRNA
expression proﬁle and up-regulated MMP-3 and MMP-13 mRNA expression in NP cultures. Data shown as geometric mean of relative target gene expression normalised to two
internal reference genes (GAPDH and 18S) and untreated controls ± 95% conﬁdence intervals. * indicates signiﬁcant alteration in mRNA expression proﬁle compared to unstimulated
control (P < 0.05). Individual patient responses for Aggrecan, MMP 3 and MMP 13 mRNA expression following stimulation with 0 and 100 ng/ml IL-1, IL-16, CCL2, CCL3, CCL7 and
CXCL8. Each dot plotted shows target gene expression normalised to two internal reference genes (GAPDH and 18S) and the individual patients 0 ng/ml. Gene expression for
aggrecan following IL-1 stimulation performed in 5 patient whilst all other genes and stimulations performed in 3 independent IVD samples from 3 different patients.
K.L.E. Phillips et al. / Osteoarthritis and Cartilage 23 (2015) 1165e1177 1171herniated human IVDs48,49, this is the ﬁrst report of CD4, CCR1,
CXCR1 and CXCR2 expression localised to native NP cells.
Differential expression patterns were observed for CD4 and
CXCR2 during degeneration which may indicate an alteration innative NP cell sensitivity to chemokine signalling in IVD pathology.
Our previous investigations concluded that IL-16 expression was
not signiﬁcantly altered in degenerate and inﬁltrated IVDs when
compared to non-degenerate counterparts40. Here, we observed
Fig. 4. IL-1b Stimulated Expression of IL-1b, IL-16, CCL2, CCL3, CCL7 and CXCL8 mRNA in Primary Human NP Cultures. Basal expression of IL-16, CCL2, CCL7 and CXCL8 but not IL-1b
or CCL3 was recorded in NP cultures. IL-1b stimulation down regulated IL-16 mRNA expression and up-regulated CCL2, CCL7 and CXCL8 mRNA expression. IL-1b stimulation induced
expression of IL-1b and CCL3 mRNA. Data shown as relative target gene expression normalised to two internal reference genes (GAPDH and 18S) and untreated controls ± 95%
conﬁdence intervals. * indicates signiﬁcant alteration in mRNA expression proﬁle compared to unstimulated control (P < 0.05). Individual patient responses for IL-16, CCL2, CCL7 and
CXCL8 mRNA expression following stimulation with 0 and 100 ng/ml IL-1, IL-16, CCL2 (CCL2 mRNA only), CCL3, CCL7 and CXCL8 (CCL2 mRNA only). Each dot plotted shows target
gene expression normalised to two internal reference genes (GAPDH and 18S) and the individual patient's 0 ng/ml. No mRNA expression for IL-1 and CCL3 was observed in NP cells
stimulated with IL-16, CCL2, CCL3, CCL7 or CXCL8 (not shown as negative). Gene expression for IL-16 following IL-1 stimulation performed in 5 patients, CCL7 in 4 patients whilst all
other genes and stimulations performed in 3 independent IVD samples from 3 different patients.
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Fig. 5. IL-1b Stimulated Cytokine Release from Primary Human NP Cultures. IL-1b stimulated release of IL-4, IL-6, IL-10, TNF-a, IFN-g and CSF2 from NP cultures. Data shown is
cytokine concentration in culture supernatant following IL-1b stimulation for each replicate with each patient represented as separate colour, median value for each patient shown *
indicates signiﬁcant increase in cytokine concentration compared to unstimulated control (P < 0.05).
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inﬁltrated IVDs, although it remains unclear as to whether this
ﬁnding implicates IL-16 as a mediating factor in the pathogenesis of
IVD degeneration or represents an attempt at the cellular level to
re-establish homeostasis. Equivalent levels of CCR1 expression by
NP cells was observed in all tissue sections irrespective of study
group suggesting sensitivity to chemokine signalling through this
receptor is maintained in IVD pathology. Previously, we showed
increased expression of CCL3, CCL4 and CCL7 in degenerate IVDs
compared to non-degenerate counterparts and CCL2 expression
was seen to increase concordant to degenerative tissue changes37,40
all of which may signal through the CCR1 receptor. High levels of
CXCR1 expression were recorded in all tissue sections irrespective
of study group. CXCR2 expression was also observed, although at
lower levels in non-degenerate NP samples than CXCR1. CXCR2
expression increased with increasing severity of histological
degeneration, up to levels comparable to that of CXCR1 expression.
We have previously shown expression of CXCL8, a chemokine
ligand with afﬁnity for both CXCR1 and CXCR2, to be increased with
grade of degeneration40. Together these ﬁndings indicate that
increased CXCL8 expression and an increasing sensitivity to CXCL8
signalling through up-regulation of CXCR2 could occur during IVD
degeneration.
In vitro stimulations of primary human NP cultures with re-
combinant human chemokines were performed to determine the
effects of stimulation of the detected chemokine receptors. Inter-
estingly, no signiﬁcant effects were observed in mRNA levels
related to ECM remodelling or inter-regulation of other chemokines
following any of the chemokine stimulations, although this may
have been speciﬁc to the patients investigated. This observation
may represent a tissue speciﬁc difference between the IVD and
articular cartilage, where chondrocytes are reported to up-regulate
factors associated with ECM degradation in response to chemokine
stimulation31e33. Primary human NP cultures were also stimulated
with recombinant human IL-1b at concentrations lower than thosepreviously investigated (1e100 pg/ml) together with concentra-
tions equivalent to those previously investigated (1e100 ng/ml).
Signiﬁcant regulatory potential on all cytokines and chemokines
investigatedwere observed following IL-1 stimulation. This ﬁnding,
together with the observation that stimulation with any other re-
combinant human chemokine investigated did not elicit modula-
tion of IL-1 transcription, suggests that chemokine expression by
NP cells is a later step in a cytokine and chemokine signalling
cascade, and any inhibition in chemokine expression would be
dependent (at least in part) on inhibition of IL-1.
Effects in response to IL-1 stimulation on ECM remodelling were
also observed, where for the ﬁrst time the differential expression of
ECM associated genes in response to very low concentrations of IL-
1bwere demonstrated. Of particular interest was the observation of
a biphasic, dose dependent, aggrecan mRNA expression pattern,
whereby low concentration stimulation increased transcription,
while high dose decreased transcription. The identiﬁcation of IL-1
expression in the healthy IVD was shown previously25 however,
all further studies into the effects of IL-1 stimulation have reported
only detrimental ECM remodelling effects23,25e27. These observa-
tions may be the ﬁrst evidence of a beneﬁcial effect mediated by IL-
1, since remodelling would be in favour of replenishing the hy-
drophilic proteoglycan ECM content and degradation of the ﬁbrous
content. These ﬁndings support a biological role for IL-1 in the
normal IVD and suggest only dysregulated expression would be
detrimental. A hypothesis further supported by a recent study in
which mice deﬁcient in the endogenous inhibitor of IL-1: Inter-
leukin-1 Receptor Antagonist, and therefore unable to regulate IL-1
expression, spontaneously developed degenerative IVD changes in
comparison to their wild type counterparts50.
From these investigations we conclude that chemokine
expression in the IVD is not directly related to ECM remodelling, a
parameter that is affected in IVD degeneration. The roles therefore,
of chemokines in the healthy and pathological IVD remain to be
elucidated. However it should be noted that the in vitro culture of
Fig. 6. IL-1b Stimulated Chemokine Release from Primary Human NP Cultures. IL-1b stimulated release of CCL2, CCL3, CCL4, CCL5, CCL7, CXCL1, CXCL8, CXCL9 and CXCL10 from NP
cultures. Data shown is cytokine concentration in culture supernatant following IL-1b stimulation for each replicate with each patient represented as separate colour, median value
for each patient shown * indicates signiﬁcant increase in cytokine concentration compared to unstimulated control (P < 0.05).
K.L.E. Phillips et al. / Osteoarthritis and Cartilage 23 (2015) 1165e11771174primary NP cells performed within this study and many others
investigating cytokine regulation have been undertaken within
normoxic conditions, which of course is not truly representative of
the in vivo hypoxic environment of the IVD. Thus it is possible were
these studies performed under hypoxic conditions chemokine
stimulation may display regulation of catabolic and anabolic pro-
cesses. It is conceivable, as NP cells express chemokine receptors,
that chemokines may be involved in the trafﬁcking of native cells
within the IVD. Supported by the ﬁnding that CXCL1 and CXCL10
chemokine stimulation promotes AF cell migration in vitro51. From
these studies we hypothesise that the chemotactic stimuli pro-
duced by native IVD cells within the healthy IVD act upon native
IVD cells, in an autocrine/paracrine manner, forming an important
control in maintaining tissue homeostasis. In disease however,
these factors may act upon other target cells and hence result in cell
inﬁltration such as leukocyte trafﬁcking, which is commonly
observed within the degenerate IVD48,52e54. We have previously
described a mechanism by which NP cell expression of CCL3 in-
duces macrophage migration into the IVD via CCR1 signalling37.
Chemokine expression could also be partly responsible for the
vascularisation seen during IVD degeneration, Lee et al. (2011)demonstrated that IL-1b expression correlates positively with
vascular endothelial growth factor (VEGF) expression and postu-
lated that IL-1b stimulated expression of VEGF drives vascularisa-
tion of the degenerate IVD55. Here, IL-1b stimulation up-regulated
NP cell release of CXCL8, an angiogenic chemokine previously
demonstrated to be increased in degenerate IVDs40. Thus, IL-1b
modulated CXCL8 expression could further induce vascularisation
of the degenerate and prolapsed IVDs which could play a role in the
spontaneous resorption of sequestered IVD fragments53. It may
even be possible to utilise the chemotactic gradient set up by native
IVD cells in therapeutic approaches, CCL5 has recently been shown
to be important in tissue directed mesenchymal stem cell homing
to the diseased IVD56e58.
Interestingly, while IL-1 stimulation up-regulated transcription
of all other chemokines and induced its own transcription, IL-16
mRNA transcript levels decreased. This is the ﬁrst report of IL-1
and IL-16 inter-regulation outside of the ﬁeld of leukocyte
biology, and hence this observation is difﬁcult to interpret. While
CD4 receptor interaction is required for all known inter-/extra-
cellular biological functions of secreted IL-1659,60, intracellular
proIL-16 is also suggested to be biologically active61.
K.L.E. Phillips et al. / Osteoarthritis and Cartilage 23 (2015) 1165e1177 1175This study demonstrates for the ﬁrst time that NP cells express a
number of cytokine and chemokine receptors and thus could
respond in an autocrine or paracrine manner to cytokines and
chemokines produced by NP cells, particularly during degenera-
tion. However, only IL-1 was shown to regulate ECM associated
genes and other cytokine and chemokine mRNA levels. In addition
IL-1 was shown to induce protein expression of a pleathora of cy-
tokines and chemokines which was enabled by the use of luminex
multiplex technology to quantify levels of 10 cytokines and 10
chemokines simultaneously within conditioned media, many of
which have not been shown previously. This suggests that IL-1 is a
master regulator within the IVD and may exert regulatory potential
over a number of other cytokines and chemokines. The roles of
these cytokines and chemokines remain to be elucidated, but may
be in the trafﬁcking of IVD, inﬂammatory, vascular endothelium,
and potentially stem cells.
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